Save
Email
Print
Share
RSS
Promising Results in Treating a Lymphoma in Young People
Patients with a type of
cancer known as primary
mediastinal B-cell lymphoma
who received infusions of
chemotherapy, but who did
not have radiation therapy
... > full story
New Monoclonal Antibody Developed That Can Target Proteins Inside Cancer Cells
Scientists have created a
unique monoclonal antibody
that can effectively reach
inside a cancer cell. ... > full story
Discovery of New Class of Damage-Prone DNA Regions Could Lead to Better Cancer Treatments
Cancer is thought to arise
from DNA damage at fragile
sites in the genome. A new
study reveals a new class of
fragile sites that
... > full story
Scientists Seek out Cancer Cells Hiding from Treatment
Funding to improve leukemia
treatment will investigate
how cancer cells hide to
avoid chemotherapy drugs. ... > full story
Browse News Stories
1 to 10 of 313 stories
view headlines only
-
TCE Exposure Linked to Increased Risk of Some Cancers
May 30, 2013 — Trichloroethylene (TCE) exposure has possible links to increased liver cancer risk, and the relationship between TCE exposure and risks of cancers of low incidence and those with confounding by ... > full story -
Radioactive Nanoparticles Target Cancer Cells
May 21, 2013 — Researchers have found a way to create radioactive nanoparticles that target lymphoma tumor cells wherever they may be in the ... > full story -
Master Regulator That Drives Majority of Lymphoma Discovered
May 13, 2013 — A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However medical researchers now ... > full story -
Immunotherapy Showed Promising Antileukemia Activity in Pediatric Patients
April 7, 2013 — Researchers using patients' own immune cells in an immunotherapy approach called "anti-CD19 chimeric antigen receptor (CAR) T-cell therapy," achieved responses in children whose acute lymphocytic ... > full story -
Cell Reprogramming to Cure Leukemia and Lymphoma?
April 2, 2013 — Researchers have reprogrammed lymphoma and leukemia cells to halt their malignancy. Resulting cells remained benign even when no longer subjected to treatment and patients were less likely to develop ... > full story -
New Type of Deadly Lymphoma Identified; Discovery Enables More Effective Treatment for Patients
April 1, 2013 — An international research team has identified a new type of deadly intestinal lymphoma that is particularly common in Asia. The team also developed a new diagnostic test to accurately identify these ... > full story -
Scientists Discover How to Shutdown Cancer's Powerful Master Protein
March 3, 2013 — The powerful master regulatory transcription factor called Bcl6 is key to the survival of a majority of aggressive lymphomas, which arise from the B-cells of the immune system. The protein has long ... > full story -
New Clues to Epstein-Barr Virus
February 21, 2013 — Epstein-Barr virus (EBV) affects more than 90 percent of the population worldwide and was the first human virus found to be associated with cancer. Now, researchers have broadened the understanding ... > full story -
Experimental Drug Combination Selectively Destroys Lymphoma Cells
February 6, 2013 — Laboratory experiments suggest that a novel combination of the drugs ibrutinib and bortezomib could potentially be an effective new therapy for several forms of blood cancer, including diffuse large ... > full story -
High-Dose Vorinostat Effective at Treating Relapsed Lymphomas, Study Suggests
February 4, 2013 — Patients whose aggressive lymphomas have relapsed or failed to respond to the current front-line chemotherapy regimen now have an effective second line of attack against their ... > full story
Search ScienceDaily
Number of stories in archives: 138,521
more 
